InsidersTradesSigma
Follow the 옵투스제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 옵투스제약 has logged 12 public disclosures. Market capitalisation: €89.4bn. The latest transaction was reported on 12 June 2026 (Purchase). Among the most active insiders: 옵투스제약. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
Optus Pharmaceutical is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products.